Expand SNOMED histology/morphology value set. - MCODE #92

XMLWordPrintableJSON

    • Type: Change Request
    • Resolution: Persuasive with Modification
    • Priority: Medium
    • US Minimal Common Oncology Data Elements (mCODE) (FHIR)
    • STU3
    • Clinical Interoperability Council
    • ValueSet [deprecated]
    • HistologyMorphologyB
    • Hide

      We recognize that the missing terms in the value set does not include those identified by cancer registries, and we will work with the CDC on adding missing terms to the value set.

      Proposed Resolution: Persuasive with Mod

      Show
      We recognize that the missing terms in the value set does not include those identified by cancer registries, and we will work with the CDC on adding missing terms to the value set. Proposed Resolution: Persuasive with Mod
    • May Terry/Richard Esmond: 11-0-0
    • Correction
    • Non-substantive

      Comment:

      Existing wording: "VS Definition: Codes representing the structure, arrangement, and behavioral characteristics of tumors and cancer cells. Codes are preferrably taken from the SNOMED CT hierarchy under 367651003

      Proposed wording: Recommend use of this value set instead: Value Set: Morphologic Abnormality of Neoplasms 2.16.840.1.114222.4.11.7256

      Contains codes descending from the following SNOMED CT® concepts: Malignant neoplasm of primary, secondary, or uncertain origin (morphologic abnormality) [367651003], Nervous system tumor morphology (morphologic abnormality) [253061008], Intratubular malignant germ cells (morphologic abnormality) [128902002], In situ melanocytic morphology (morphologic abnormality) [253035009], In situ neoplasm (morphologic abnormality) [127569003], Carcinoma in situ - category (morphologic abnormality) [399919001], Squamous intraepithelial neoplasia - category (morphologic abnormality) [399962000], In situ adenomatous neoplasm - category (morphologic abnormality) [399983006].

      Also includes following SNOMED CT codes and any descendants of such codes: Chronic myeloproliferative disorder (morphologic abnormality) [115248004], Cavernous lymphangioma (morphologic abnormality) [89056007], Paraganglioma (morphologic abnormality) [803009], Craniopharyngioma (morphologic abnormality) [40009002], Craniopharyngioma, adamantinomatous (morphologic abnormality) [128781004], Craniopharyngioma, papillary (morphologic abnormality) [128782006], Pineocytoma (morphologic abnormality) [89096009], Pleomorphic adenoma (morphologic abnormality) [8360001], Intratubular malignant germ cells (morphologic abnormality) [128902002].

      We recommend using the value set developed for the HL7 CDA® R2 IG: Reporting to Public Health Cancer Registries from Ambulatory Healthcare Providers, R1, DSTU Release 1.1 - US Realm (https://www.hl7.org/implement/standards/product_brief.cfm?product_id=398) because using the value set currently in the IG would result in missed cancer cases.

      We do recognize that the proposed value set includes non-solid tumor values which would need to be removed; we are happy to assist with that effort.

      Summary:

      Expand SNOMED histology/morphology value set.

            Assignee:
            May Terry
            Reporter:
            wendyblumenthal
            Watchers:
            4 Start watching this issue

              Created:
              Updated:
              Resolved: